Funder
Cystinosis Foundation
H2020 Societal Challenges
Subject
Genetics(clinical),Genetics
Reference29 articles.
1. Almaca J, Faria D, Sousa M et al (2013) High-content siRNA screen reveals global ENaC regulators and potential cystic fibrosis therapy targets. Cell 154:1390–1400
2. Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3:673–683
3. Banfi C, Baetta R, Gianazza E, Tremoli E (2017) Technological advances and proteomic applications in drug discovery and target deconvolution: identification of the pleiotropic effects of statins. Drug Discov Today doi:10.1016/j.drudis.2017.03.001
4. Bittker JA, Ross NT (2016) High throughput screening methods: evolution and refinement. Royal Society of Chemistry, UK
5. Bray MA, Carpenter A, Imaging Platform, Broad Institute of MIT and Harvard (2004) Advanced assay development guidelines for image-based high content screening and analysis. In Sittampalam GS, Coussens NP, Brimacombe K, et al, eds. Assay guidance manual. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献